Skip to main content
Log in

Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Data on the management of male infertility secondary to hypogonadotrophic hypogonadism (HH) are limited. We report our extensive experience with intramuscular injections of gonadotropins, one of the two methods used for this purpose. Eighty-seven married men (median age, 28 years) with either congenital (47 men) or acquired (40 men) HH were treated for a median of 26 months (range, 6–57) with intramuscular injections of gonadotropins (HCG/HMG) three times weekly for the purpose of achieving fertility. The outcome was assessed by achievement of one or more pregnancies. Of the 151 courses of HCG/HMG treatment administered to 87 patients, 85 courses (56.3%) were successful, resulting in 85 pregnancies (median pregnancy rate 2, range 1–10) in 35 patients (40%) while 52 cases did not achieve pregnancy. Responders had larger pretherapy testicular volume (9 ± 3.6 cc) compared to non-responders [(5.7 ± 2.0 cc), P < 0.0001], but there was no difference in age, LH, FSH or testosterone levels or doses of HCG/HMG used. The pregnancy rate was similar in those with congenital (51.4%) and acquired causes (48.6%) of HH (P = 0.83). Only testicular size was predictive of conception (P < 0.001, odds ratio 1.5, 95% CI 1.21–1.92) while age, pretherapy levels of testosterone, LH, FSH and doses of HCG/HMG did not predict the success of pregnancy. Gonadotropins are moderately effective in achieving one to several pregnancies in HH. Only testicular size is predictive of success in achieving pregnancy. There is no difference in success between those with congenital and acquired causes of HH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zitzmann M, Nieschlag E (2000) Hormone substitution in male hypogonadism. Mol Cell Endocrinol 161:73–88

    Article  CAS  PubMed  Google Scholar 

  2. Kliesch S, Behre HM, Nieschlag E (1994) High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 131:347–354

    Article  CAS  PubMed  Google Scholar 

  3. Buchter D, Behre HM, Kliesch S et al (1998) Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 139:298–303

    Article  CAS  PubMed  Google Scholar 

  4. Liu L, Banks SM, Barnes KM et al (1988) Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 67:1140–1145

    Article  CAS  PubMed  Google Scholar 

  5. Finkel DM, Phillips JL, Snyder PJ (1985) Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 313:651–655

    Article  CAS  PubMed  Google Scholar 

  6. Burger HG, Baker HW (1984) Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann N Y Acad Sci 438:447–453

    Article  CAS  PubMed  Google Scholar 

  7. Burgues S, Calderon MD (1997) Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod 12:980–986

    Article  CAS  PubMed  Google Scholar 

  8. Liu PY, Gebski VJ, Turner L et al (2002) Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 17:625–633

    Article  PubMed  Google Scholar 

  9. Bouloux PM, Nieschlag E, Burger HG et al (2003) Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 24:604–611

    CAS  PubMed  Google Scholar 

  10. Miyagawa Y, Tsujimura A, Matsumiya K et al (2005) Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 173:2072–2075

    Article  CAS  PubMed  Google Scholar 

  11. Ishikawa T, Ooba T, Kondo Y et al (2007) Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril 88:1697–1699

    Article  CAS  PubMed  Google Scholar 

  12. Pitteloud N, Hayes FJ, Dwyer A et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136

    Article  CAS  PubMed  Google Scholar 

  13. Liu PY, Gordon Baker HW, Jayadev V et al (2008) Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab 94:801–808

    Article  PubMed  CAS  Google Scholar 

  14. Liu PY, Handelsman DJ (2003) The present and future state of hormonal treatment for male infertility. Hum Reprod Update 9:9–23

    Article  CAS  PubMed  Google Scholar 

  15. Delemarre-van de Waal HA (2004) Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism—diagnostic and therapeutic aspects. Eur J Endocrinol 151(Suppl 3):U89–94

    Article  CAS  PubMed  Google Scholar 

  16. Blumenfeld Z, Makler A, Frisch L et al (1988) Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecol Endocrinol 2:151–164

    Article  CAS  PubMed  Google Scholar 

  17. Spratt DI, Finkelstein JS, O’Dea LS et al (1986) Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone’s physiologic effects. Ann Intern Med 105:848–855

    CAS  PubMed  Google Scholar 

  18. Crowley WF Jr, Filicori M, Spratt DI et al (1985) The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41:473–531

    CAS  PubMed  Google Scholar 

  19. Belchetz PE, Plant TM, Nakai Y et al (1978) Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 202:631–633

    Article  CAS  PubMed  Google Scholar 

  20. Liu PY, Swerdloff RS, Anawalt BD et al (2008) Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 93:1774–1783

    Article  CAS  PubMed  Google Scholar 

  21. Ley SB, Leonard JM (1985) Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab 61:746–752

    Article  CAS  PubMed  Google Scholar 

  22. Burris AS, Rodbard HW, Winters SJ et al (1988) Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 66:1144–1151

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali S. Alzahrani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farhat, R., Al-zidjali, F. & Alzahrani, A.S. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary 13, 105–110 (2010). https://doi.org/10.1007/s11102-009-0203-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-009-0203-1

Keywords

Navigation